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Objective: The aim of this study was to investigate the asso-
ciation of obesity with in- hospital coronavirus disease 2019 
(COVID- 19) outcomes in different ethnic groups.
Methods: Patients admitted to hospital with COVID- 19 in the 
United Kingdom through the Clinical Characterisation Protocol 
UK (CCP- UK) developed by the International Severe Acute 
Respiratory and emerging Infections Consortium (ISARIC) were 
included from February 6 to October 12, 2020. Ethnicity was 
classified as White, South Asian, Black, and other minority eth-
nic groups. Outcomes were admission to critical care, mechani-
cal ventilation, and in- hospital mortality, adjusted for age, sex, 
and chronic diseases.
Results: Of the participants included, 54,254 (age = 76 years; 
45.0% women) were White, 3,728 (57 years; 41.1% women) 
were South Asian, 2,523 (58 years; 44.9% women) were Black, 
and 5,427 (61 years; 40.8% women) were other ethnicities. 
Obesity was associated with all outcomes in all ethnic groups, 
with associations strongest for black ethnicities. When stratified 
by ethnicity and obesity status, the odds ratios for admission to 
critical care, mechanical ventilation, and mortality in black eth-
nicities with obesity were 3.91 (3.13- 4.88), 5.03 (3.94- 6.63), and 
1.93 (1.49- 2.51), respectively, compared with White ethnicities 
without obesity.
Conclusions: Obesity was associated with an elevated risk of 
in- hospital COVID- 19 outcomes in all ethnic groups, with asso-
ciations strongest in Black ethnicities.
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What is already known?
►	People of South Asian or Black ethnic origin have 
been shown to have a higher risk of infection, severe 
disease, and coronavirus disease 2019 (COVID- 19) 
mortality compared with those of White ethnicities.
►	Obesity is an established risk factor for COVID- 19 
outcomes, but less is known about whether 
ethnicity acts to modify the strength of association 
observed with obesity or whether the risk remains 
consistent across ethnic groups.
What does this study add?
►	Compared with White individuals without obesity, 
all other combinations of obesity and ethnicity had 
a higher risk of admission to critical care, receiving 
mechanical ventilation, or mortality in those 
admitted to hospital with COVID- 19. However, the 
risk of all outcomes was greatest in those of Black 
ethnicity with obesity.
How might these results change the direction 
of research or the focus of clinical practice?
►	Black ethnic groups with obesity represent a 
particularly high- risk group of patients, with 
implications for targeted public health and 
vaccination strategies and for identifying those 
most likely to suffer severe outcomes once 
admitted to hospital.
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Introduction
Obesity and ethnicity are well- described risk factors for coronavirus 
disease 2019 (COVID- 19) outcomes (1- 7). People of South Asian or 
Black ethnic origin, in particular, have been shown to carry a higher risk 
of infection, severe disease, and COVID- 19 mortality compared with 
those of White ethnicities (1- 5). In addition, individuals with obesity 
have around twice the risk of severe outcomes or mortality compared 
with normal- weight individuals (6,7). However, although obesity and 
ethnicity were shown to be independent of each other as risk factors 
for COVID- 19 outcomes, less is known about whether ethnicity acts to 
modify the strength of association observed with obesity or whether the 
risk remains consistent across different ethnic groups.
The hypothesis that ethnicity may modify associations between obe-
sity and COVID- 19 outcomes is drawn from previous research, sug-
gesting that the dose– repose relationship between levels of obesity and 
cardiometabolic health is steeper in minority ethnic communities com-
pared with White populations: indeed, the higher the BMI, the greater 
the difference in health outcomes between minority ethnic groups and 
White Europeans (8- 12). As cardiometabolic diseases are known risk 
factors for COVID- 19 outcomes (13- 16), it is possible that obesity may 
also act as a particularly important risk factor for severe COVID- 19 
outcomes in minority ethnic communities. Early research supports 
this hypothesis, in which the risk of severe acute respiratory syndrome 
coronavirus 2 infection, severe disease, and COVID- 19 mortality in 
minority ethnic communities has been shown to be magnified in the 
presence of obesity (17,18), although this has not been confirmed in 
all studies (19). However, evidence to date is preliminary and based on 
small cohorts with a limited number of outcomes, with minority eth-
nic groups analyzed as one category. As minority ethnic groups cover 
heterogeneous populations, it remains uncertain whether associations 
between obesity and COVID- 19 outcomes differ in all minority ethnic 
groups or how they apply to national in- hospital settings.
Investigating whether obesity is a stronger risk factor for in- patient 
outcomes in specific minority ethnic groups will help inform public 
health and vaccination strategies aimed at identifying and targeting 
patients at greatest risk along with informing in- hospital clinical 
decision- making. In this view, we investigated associations of obesity 
and ethnicity with in- hospital critical care and mortality outcomes 
in patients admitted with COVID- 19 using data from the Clinical 
Characterisation Protocol UK (CCP- UK), a preparedness protocol 
for severe emerging diseases developed by the International Severe 
Acute Respiratory and emerging Infections Consortium (ISARIC) 
cohort (20). Previous ISARIC CCP- UK publications have helped 
characterize in- hospital patients admitted with COVID- 19 (21) and 
have shown a greater risk of in- hospital outcomes with both obesity 
and ethnicity (21,22) during early phases of the pandemic. Having 
previously established independent associations, this paper investi-
gates their interaction.
We hypothesized that obesity will be a stronger risk factor for in- 
hospital outcomes within some minority ethnic groups.
Methods
Cohort
The protocol, amendment history, case report form, information leaf-
lets, consent forms, and details of the Independent Data and Material 
Access Committee for ISARIC CCP- UK are available at https://isari 
c4c.net. The study was approved by the South Central - Oxford C 
Research Ethics Committee in England (Reference 13/SC/0149) 
and by the Scotland Research Ethics Committee (Reference 20/
SS/0028). For this study, we included participants with a coding of 
“Proven or high likelihood of infection with a pathogen of Public 
Health Interest,” reflecting that a preparedness protocol cannot as-
sume a diagnostic test will be available for an emergent pathogen. 
From January 2020 onward, site training also emphasized the im-
portance of only recruiting proven cases of COVID- 19. Participants 
were included in the analysis if information was available on hospital 
admittance date from the emergence of the COVID- 19 pandemic in 
the United Kingdom (UK) (February 6, 2020); a completed coding 
indicating that the hospital admission had been resolved through dis-
charge or in- hospital mortality; and ethnicity status. Data were avail-
able up until October 12, 2020.
Data were directly transcribed from routine health care into case 
report forms hosted on a Research Electronic Data Capture database 
(REDCap; https://proje ctred cap.org). Data collection was undertaken 
by research nurses, administrators, and medical students. Detailed 
demographic and clinical data were collected on admission, with fol-
low- up data on clinical care collected at day 3, 6, and 9. The outcome 
of hospital admission was coded on discharge or death.
Exposures. Obesity was coded as yes or no on assessment from 
the attending clinician. Clinical assessment was based on objective 
measurement of obesity, such as BMI (BMI ≥ 30 kg/m2) or abdominal 
girth, or on clinical judgment.
Ethnicity was transcribed from health care records. In order to be 
consistent with internationally applicable ethnicity definitions, eth-
nicity within ISARIC was classified as East Asian, South Asian, West 
Asian, Black, White, Latin American, aboriginal/First Nations, and 
other ethnic minority. For the purposes of this analysis and based on 
frequency, ethnicity was categorized as White, South Asian, Black, 
or other (East Asian, West Asian, Arab, Latin American, Aboriginal/
First Nations, other).
Covariates. Age was measured to the nearest year based on the 
difference between date of birth and hospital admission date. Sex was 
coded as male or female. Chronic disease was based on clinician- 
diagnosed status. In this study, we included diseases that have been 
consistently associated with COVID- 19 outcomes (13- 16): chronic 
cardiac disease (coronary artery disease, heart failure, congenital heart 
disease, cardiomyopathy, rheumatic heart disease), chronic kidney 
disease (diagnosed chronic kidney disease or estimated glomerular 
filtration rate <60 mL/min/1.73 m2), chronic pulmonary disease (chronic 
obstructive pulmonary disease [chronic bronchitis, emphysema], 
cystic fibrosis, bronchiectasis, interstitial lung disease, preexisting 
requirement for long- term oxygen therapy), diabetes (type 1 or 2), and 
malignant neoplasm (current solid organ or hematological malignancy). 
In- hospital treatment for COVID- 19 was coded at discharge or death. 
The two main treatment types of oral or intravenous corticosteroids 
(including dexamethasone) and antivirals were included in this analysis.
Outcome. The main outcomes were admission to a critical care 
facility (intensive care unit [level 3] or high- dependency unit [level 
2]), any deployed usage of a mechanical ventilation procedure 
(tracheal intubation or tracheostomy), and in- hospital mortality.
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We use logistic regression to quantify associations between obesity 
and outcomes stratified by ethnicity: odds ratios (ORs) were adjusted 
for age, sex, and the presence of comorbidities (diabetes, chronic 
heart disease, chronic kidney disease, chronic pulmonary disease, 
and cancer). Stratified analysis was undertaken to assess whether the 
pattern of association of obesity with assessed outcomes in each eth-
nic group was consistent across strata of age (<70 years, ≥70 years), 
sex and presence of any chronic disease (defined as diabetes, chronic 
heart disease, chronic kidney disease, chronic pulmonary disease, 
and cancer).
To further assess the pattern of associations for both obesity and eth-
nicity, we defined mutually exclusive groups of ethnicity and obesity 
and estimated ORs in each category compared with White individuals 
without obesity (reference group). Sensitivity analysis was under-
taken to assess whether the association between mutually exclusive 
groups of ethnicity and obesity with mortality were independent of 
in- hospital corticosteroid and antiviral treatments.
In order to account for missing obesity and covariate data, all analysis 
was conducted using multiple imputation through the Markov chain 
Monte Carlo imputation algorithm across five iterations. Associations 
with obesity within each ethnicity were also derived using a complete 
case data set as a sensitivity analysis.
All analyses were conducted in SPSS version 26 (IBM Corp., Armonk, 
New York). Data are reported with 95% CI unless reported otherwise; 
P < 0.05 was considered significant (e.g., in which the 95% CI does 
not cross the null).
Results
Of the 65,932 individuals included in this analysis, 54,254 (82.3%) 
were White, 3,728 (5.7%) South Asian, 2,523 (3.8%) Black, and 
5,427 (8.8%) from other ethnic minorities: Table 1 shows the charac-
teristics of the cohort. Compared with White individuals, all minority 
ethnic groups were younger. Black ethnicities had the highest fre-
quency of coded obesity (13.0%), although there was no difference 
compared with White individuals when accounting for differences 
in age and sex (OR 1.00; 95% CI: 0.88- 1.13). Conversely, age and 
sex adjusted frequencies were lower in South Asian (0.84; 95% CI: 
0.76- 0.94) and other minority ethnic groups (0.76; 95% CI: 0.69- 
0.84) than in White individuals. When adjusted for age and sex, all 
minority ethnic groups had a higher risk of in- hospital outcomes, 
with associations persisting after further adjustment for obesity and 
chronic disease (Table 2). For example, compared with White eth-
nicities, South Asian (1.27; 95% CI: 1.17- 1.38), Black (1.19; 95% 
CI: 1.08- 1.32), and other ethnicities (1.12; 95% CI: 1.04- 1.21) had a 
higher risk of mortality.
Obesity was consistently associated with admission to critical care, 
mechanical ventilation, and mortality in all ethnic groups (Table 3). 
However, for all outcomes, the association with obesity was strongest 
in Black ethnicities. For example, in White ethnicities, the OR for 
mortality in those with obesity compared with those without obesity 
was 1.23 (95% CI, 1.15- 1.32) whereas it was 1.98 (95% CI: 1.46- 
2.68) for Black ethnicities. The association between obesity and 
in- hospital mortality in South Asian (1.34; 95% CI: 1.03- 1.76) and 
other (1.22; 95% CI: 0.91- 1.62) minority ethnic groups was similar in 
magnitude to White ethnicities (Table 3). The pattern of association 
of obesity within each ethnic group was the same when the analysis 
was restricted to a complete case data set (Supporting Information 
Table S1). Associations within each ethnic group were also similar 
in men and women (Figure 1) but tended to be weaker in those with 
chronic disease or older (≥70 years) adults, particularly for mortality 
(Figure 1), in which no associations were seen in older adults for any 
ethnicity. The strongest association for obesity with mortality within 
assessed strata was observed in Black ethnicities without coexisting 
chronic disease (OR = 2.95; 95% CI: 1.84- 4.74) (Figure 1).
Figure 2 shows the association of mutually exclusive categories of 
obesity and ethnicity with outcomes. Compared with White ethnici-
ties without obesity, all other combinations of obesity and ethnicity 
had a higher risk of admission to critical care or having mechanical 
ventilation, with obesity having a stronger association with risk than 
ethnicity. For example, the OR of admission to a critical care facility 
in Black ethnicities without obesity was 1.54 (95% CI: 1.38- 1.73) 
compared with White ethnicities without obesity, whereas the OR 
in Black ethnicities with obesity was 3.91 (95% CI: 3.13- 4.88). The 
same comparisons for mechanical ventilation were 1.99 (95% CI: 
1.74- 2.27) and 5.03 (95% CI: 3.94- 6.63), respectively (Figure 2). 
South Asian and other minority ethnic groups without obesity had a 
similar risk to Black ethnicities without obesity, but the risk in those 
with obesity was less pronounced. For mortality in those without 
obesity, risk was marginally higher for Black (1.14; 95% CI: 1.02- 
1.28), South Asian (1.27; 95% CI: 1.16- 1.40) and other (1.13; 95% 
CI: 1.05- 1.23) minority ethnic groups (Figure 2). When considering 
patients with obesity, the risk of mortality was elevated in all ethnic 
groups; those with Black ethnicity and obesity had the greatest risk 
(1.93; 95% CI: 1.49- 2.51) (Figure 2). The pattern and strength of 
association of ethnicity and obesity with mortality was not affected 
by further adjusting for in- hospital corticosteroid and antiviral treat-
ments (Supporting Information Figure S1).
Discussion
In this large national study of patients hospitalized with COVID- 19, 
obesity was associated with an increased risk of admission to critical 
care, receiving mechanical ventilation, and in- hospital mortality in all 
ethnic groups, with associations strongest in those under 70 years of age 
or without other chronic diseases. However, the risk was consistently 
strongest in Black ethnicities with obesity when compared with all other 
ethnic and obesity groupings, with a four to five times greater risk of ad-
mission to critical care or receiving mechanical ventilation and around 
twice the risk of in- hospital mortality compared with White ethnicities 
without obesity. The association of obesity with in- hospital outcomes 
was stronger than that of ethnicity; in individuals without obesity, eth-
nicity was only marginally associated with in- hospital mortality.
This study extends early preliminary findings from two different early 
analyses from the UK Biobank community cohort involving 1,087 pos-
itive cases and 189 deaths, in which obesity was a stronger predictor of 
positivity and COVID- 19 mortality in non- White ethnicities (17,18). The 
present study suggests that in patients admitted to hospital, a clinical cod-
ing of obesity is a stronger risk factor in Black ethnic groups specifically 
rather than for minority ethnic groups in general. Obesity in South Asian 
and Other ethnic minority groups carried a similar level of risk as it did 
Obesity
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TABLE 1 Cohort characteristics
White (n = 54,254) South Asian (n = 3,728) Black (n = 2,523) Other (n = 5,427)
Categorical variables Number % Number % Number % Number %
Sex
Men 29,817 55.0 2,186 58.6 1,393 55.2 3,205 59.1
Women 24,340 44.9 1,536 41.2 1,128 44.7 2,213 40.8
Missing 97 0.2 6 0.2 2 0.1 9 0.2
Chronic heart disease
No 33,016 60.9 2,630 70.5 1963 77.8 3,915 72.1
Yes 18,428 34.0 772 20.7 380 15.1 1,080 19.9
Missing 2,810 5.2 326 8.7 180 7.1 432 8.0
Chronic pulmonary disease
No 40,846 75.3 3,123 83.8 2,187 86.7 4,508 83.1
Yes 10,403 19.2 240 6.4 145 5.7 482 8.9
Missing 3,005 5.5 365 9.8 191 7.6 437 8.1
Diabetes
No 41,796 77.0 2,362 63.4 1,744 69.1 3,858 71.1
Yes 7,604 14.0 852 22.9 505 20.0 953 17.6
Missing 4,854 8.9 514 13.8 274 10.9 616 11.4
Chronic kidney disease
No 41,688 76.8 2,874 77.1 1944 77.1 4,339 80.0
Yes 9,380 17.3 495 13.3 393 15.6 633 11.7
Missing 3,186 5.9 359 9.6 186 7.4 455 8.4
Cancer
No 44,879 82.7 3,222 86.4 2,153 85.3 4,621 85.1
Yes 5,823 10.7 126 3.4 175 6.9 327 6.0
Missing 3,552 6.5 380 10.2 195 7.7 479 8.8
Antiviral treatment
No 48,286 89.0 3,096 83.0 2,086 82.7 4,558 84.0
Yes 2,914 5.4 309 8.3 251 9.9 481 8.9
Missing 3,054 5.6 323 8.7 186 7.4 388 7.1
Corticosteroid treatment
No 43,005 79.3 2,682 71.9 1995 79.1 4,135 76.2
Yes 8,108 14.9 715 19.2 340 13.5 883 16.3
Missing 3,141 5.8 331 8.9 2,335 92.5 409 7.5
Obesity
No 40,399 74.5 2,597 69.7 1,815 71.9 4,019 74.1
Yes 5,363 9.9 404 10.8 328 13.0 543 10.0
Missing 8,492 15.7 727 19.5 380 15.1 865 15.9
Mortality
No 37,236 68.6 2,845 76.3 1932 76.6 4,153 76.5
Yes 17,018 31.4 883 23.7 591 23.4 1,274 23.5
Missing 0 0 0 0 0 0 0 0
Mechanical ventilation
No 50,349 92.8 3,087 82.8 2,056 81.5 4,499 82.9
Yes 3,278 6.0 474 12.7 404 16.0 816 15.0
Missing 627 1.2 167 4.5 63 2.5 112 2.1
(Continues)
Obesity
www.obesityjournal.org  Obesity | VOLUME 00 | NUMBER 00 | MONTH 2021     5
Original Article
EPIDEMIOLOGY/GENETICS
for White ethnicities. There are several hypothesized mechanisms that 
may explain these findings. Obesity has been hypothesized to increase 
the risk of severe COVID- 19 through mechanisms linked to restricted pul-
monary function and chronic inflammation (2,23- 25); adipose tissue has 
also been suggested as a viral reservoir (24). Patients from Black ethnic-
ities may have greater inflammatory responses to infection (25- 27), and 
excessive systemic innate inflammation due to obesity (“adipositis”) is 
associated with susceptibility to other infectious diseases (28). Because 
both clinical and genetic evidence strongly suggests that inflammatory 
processes drive mortality in COVID- 19 (29,30), these mechanisms may 
place Black ethnicities with obesity at a higher risk of organ failure and 
death. It is also possible that sociodemographic factors, such as greater 
levels of deprivation and discrimination, may also act through a host of 
different mechanisms to lower resilience to infection or delay admission 
White (n = 54,254) South Asian (n = 3,728) Black (n = 2,523) Other (n = 5,427)
Critical care
No 47,590 87.7 2,796 75.0 1,895 75.1 4,151 76.5
Yes 6,132 11.3 773 20.7 570 22.6 1,173 21.6
Missing 532 1.0 159 4.3 58 2.3 103 1.9








Age (y) 76 63- 85 59 44- 73 59 47- 75 61 47- 76
TABLE 1 (Continued)
TABLE 2 The risk of critical care admission, mechanical ventilation, and in- hospital mortality in minority ethnic patients 
compared with White patients
In- hospital outcome White South Asian Black Other
Model 1
Critical care admission Reference 1.40 (1.28- 1.53) 1.66 (1.49- 1.83) 1.53 (1.42- 1.65)
Mechanical ventilation Reference 1.57 (1.40- 1.76) 2.17 (1.94- 2.44) 1.99 (1.82- 2.17)
Mortality Reference 1.25 (1.15- 1.46) 1.18 (1.06- 1.30) 1.09 (1.02- 1.17)
Model 2
Critical care admission Reference 1.37 (1.26- 1.50) 1.58 (1.43- 1.75) 1.51 (1.40- 1.62)
Mechanical ventilation Reference 1.49 (1.33- 1.68) 2.03 (1.80- 2.28) 1.91 (1.75- 2.09)
Mortality Reference 1.27 (1.17- 1.38) 1.19 (1.08- 1.32) 1.12 (1.04- 1.21)
Data are given as odds ratio (95% CI). Model 1 is adjusted for age and sex. Model 2 is adjusted for age, sex, obesity, diabetes, chronic heart disease, chronic kidney disease, 
chronic pulmonary disease, and cancer.
TABLE 3 Risk of COVID- 19 outcomes in those with obesity compared with the reference of those without obesity when stratified 
by ethnicity
In- hospital outcome White South Asian Black Other
Model 1
Critical care admission 2.07 (1.91- 2.24) 1.63 (1.26- 2.11) 2.42 (1.90- 3.09) 1.94 (1.61- 2.34)
Mechanical ventilation 2.11 (1.93- 2.32) 1.66 (1.18- 2.34) 2.44 (2.15- 3.31) 1.91 (1.55- 2.34)
Mortality 1.30 (1.22- 1.38) 1.42 (1.09- 1.85) 1.98 (1.46- 2.68) 1.29 (0.97- 1.70)
Model 2
Critical care admission 2.20 (2.03- 2.38) 1.72 (1.32- 2.26) 2.50 (1.95- 3.20) 2.00 (1.66- 2.42)
Mechanical ventilation 2.27 (2.06- 2.49) 1.79 (1.27- 2.52) 2.56 (1.95- 3.37) 1.92 (1.56- 2.37)
Mortality 1.23 (1.15- 1.32) 1.34 (1.03- 1.76) 1.98 (1.46- 2.68) 1.22 (0.91- 1.62)
Data are given as odds ratio (95% CI). Reference group is those without obesity within each ethnic strata. Model 1 is adjusted for age and sex. Model 2 is adjusted for age, sex, 
diabetes, chronic heart disease, chronic kidney disease, chronic pulmonary disease, and cancer.
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to hospital (25), which again could become more severe in the presence 
of obesity. However, further research is required to disentangle the mech-
anisms behind the observations reported in this paper.
Associations with obesity in each ethnic group were consistent across men 
and women but tended to be weaker in older (≥70 years) adults or those 
with coexisting chronic disease, particularly for the outcome of mortality, 
in which no association between obesity and mortality was seen in any 
ethnic group in older adults. Although there was a high level of uncertainty 
in older minority ethnic populations due to a younger average age and the 
resulting limited sample of older adults, the findings are consistent with 
another in- hospital study in which associations of BMI with mortality or 
mechanical ventilation were largely attenuated in those over 70 years of 
age (31). Therefore, the findings from this study may only be generalizable 
to those under 70 years of age, with ethnic specific associations in older 
adults needing further investigation. Obesity may also be a particularly 
strong risk factor for severe COVID- 19 outcomes in otherwise healthy 
adults, where the highest odds of COVID- 19 mortality with obesity was 
seen in Black ethnicities without other coexisting chronic diseases.
Strengths of this analysis include the large multisite national sample 
with data captured from clinical records by trained individuals using 
standardized operating procedures, allowing the largest analysis of 
COVID- 19 outcomes with obesity and ethnicity to date. However, 
there are some important limitations. Obesity was defined through 
clinician assessment, with the prevalence an underestimate com-
pared with levels that would have been expected based on population 
estimates (32). Thus, the coding of obesity possibly reflects more 
extreme phenotypes of obesity that are likely to prompt a clinical 
coding, and it is unknown whether this procedure was biased by eth-
nicity. However, the pattern of obesity prevalence in this sample is 
broadly consistent with national survey data for overweight and obe-
sity prevalence (33), with rates higher in Black ethnic groups but 
lower in other minority ethnic groups compared with White ethnici-
ties. It is also important to note that, in order to inform clinical care, 
analyzed risk factors need to reflect data that are readily available to 
treating clinical staff through clinical records. Therefore, the coding 
of obesity in this study may have real- world utility as it corresponds 
to data collected within routine clinical care. Another potential 
Figure 1 Associations of obesity (compared with those without obesity) with critical care, mechanical ventilation, and mortality for each ethnicity stratified by age, sex, and chronic 
disease. Error bars display 95% CI. Sex strata adjusted for age, diabetes, chronic heart disease, chronic kidney disease, chronic pulmonary disease, and cancer. Age strata 
adjusted for sex, diabetes, chronic heart disease, chronic kidney disease, chronic pulmonary disease, and cancer. Chronic disease strata adjusted for age and sex.
Figure 2 Risk of admittance to critical care, mechanical ventilation, and mortality across categories of obesity and ethnicity compared with White individuals without obesity. 
Error bars display 95% CI. Adjusted for age, sex, diabetes, chronic heart disease, chronic kidney disease, chronic pulmonary disease, and cancer.
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limitation is that the coding of ethnicity was designed to be consis-
tent with international definitions, rather than those designed for the 
UK populations. As such, it is acknowledged that the terms “Black,” 
“South Asian,” “White,” and “other” cover a wide range of differ-
ent cultures and races. Consequently, our analyses may have masked 
important differences between further stratified ethnic groups. 
However, comparisons using these broad ethnic groupings are infor-
mative for understanding initial ethnic differences that can then be 
further and more granularly investigated. Finally, this analysis did 
not have access to potential sociodemographic confounders, such as 
deprivation, housing, or employment status. However, the purpose 
of this analysis was to highlight ethnic differences in the strength 
of obesity as a global risk factor for in- hospital outcomes following 
admission with COVID- 19, rather than for supporting potential etio-
logical conclusions around reducing levels of obesity per se.
In conclusion, although obesity was a consistent risk factor for 
adverse in- hospital outcomes following admission with COVID- 19 
within all ethnic groups, particularly for younger adults without coex-
isting chronic disease, the risk with obesity was greatest in Black eth-
nicities compared with other ethnic groups. Black ethnic groups with 
obesity therefore represent a particularly high- risk group of patients 
with implications for targeted public health and vaccination strategies 
and for identifying those most likely to suffer severe outcomes once 
admitted to hospital.O
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